JULIA MARIE EASTLAND Insider Trading $CASC Cascadian Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JULIA MARIE EASTLAND.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JULIA MARIE EASTLAND. JULIA MARIE EASTLAND is Director in DYNAVAX TECHNOLOGIES CORP ($DVAX) and CFO & CBO in Cascadian Therapeutics, Inc. ($CASC) and CFO & VP Corp. Dev. in Oncothyreon Inc. ($ONTY) and CFO & VP, Corp Development in Oncothyreon Inc. ($ONTY) and CFO & VP, Corp. Development in Oncothyreon Inc. ($ONTY) and Director in GRAYBUG VISION, INC. ($GRAY) and Director in Harpoon Therapeutics, Inc. ($HARP).
JULIA MARIE EASTLAND in Cascadian Therapeutics, Inc.
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of JULIA MARIE EASTLAND: CFO & CBO, CFO & VP Corp. Dev., CFO & VP, Corp Development, CFO & VP, Corp. Development
Holdings: 0 shares
Latest Transaction: Mar 13 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JULIA MARIE EASTLAND in Cascadian Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CASC, DVAX, GRAY, HARP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 0.00 | 199,000 | 0 | 0 | |
| Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 0.00 | 16,500 | 0 | 0 | |
| Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 0.00 | 11,300 | 0 | 0 | |
| Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 3.99 | 75,000 | 299,250 | 0 | |
| Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 4.64 | 51,200 | 237,568 | 0 | |
| Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 6.90 | 50,000 | 345,000 | 0 | |
| Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 21.06 | 41,667 | 877,507 | 0 | |
| Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 10.56 | 16,667 | 176,004 | 0 | |
| Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 10.44 | 25,000 | 261,000 | 0 | |
| Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 28.44 | 8,334 | 237,019 | 0 | |
| Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 41.52 | 8,334 | 346,028 | 0 | |
| Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 19.92 | 8,334 | 166,013 | 0 | |
| Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | D | 19.86 | 6,667 | 132,407 | 0 | |
| Mar 13 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Sell | U | 0.00 | 5,237 | 0 | 0 | 5.2 K to 0 (-100.00 %) |
| Feb 02 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | A | 0.00 | 199,000 | 0 | 199,000 | |
| Jan 16 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | M | 0.00 | 2,825 | 0 | 8,475 | |
| Jan 16 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Payment of Exercise | F | 3.92 | 923 | 3,618 | 5,237 | 6.2 K to 5.2 K (-14.98 %) |
| Jan 16 2018 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Buy | M | 0.00 | 2,825 | 0 | 6,160 | 3.3 K to 6.2 K (+84.71 %) |
| Sep 20 2017 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | A | 0.00 | 16,500 | 0 | 16,500 | |
| Sep 20 2017 | CASC | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & CBO | Option Exercise | A | 3.99 | 75,000 | 299,250 | 75,000 | |
| Jan 13 2017 | ONTY | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & VP Corp. Dev. | Option Exercise | A | 0.00 | 11,300 | 0 | 11,300 | |
| Jan 13 2017 | ONTY | Cascadian Therapeu ... | EASTLAND JULIA MARIE | CFO & VP Corp. Dev. | Option Exercise | A | 4.64 | 51,200 | 237,568 | 51,200 | |
| May 19 2016 | ONTY | Oncothyreon Inc. | EASTLAND JULIA MARIE | CFO & VP Corp. Dev. | Option Exercise | A | 1.15 | 300,000 | 345,000 | 300,000 | |
| Sep 28 2015 | ONTY | Oncothyreon Inc. | EASTLAND JULIA MARIE | CFO & VP Corp. Dev. | Option Exercise | A | 3.51 | 250,000 | 877,500 | 250,000 | |
| Dec 03 2010 | ONTY | Oncothyreon Inc. | EASTLAND JULIA MARIE | CFO & VP, Corp Deve ... | Option Exercise | A | 3.32 | 50,000 | 166,000 | 50,000 | |
| Nov 10 2010 | ONTY | Oncothyreon Inc. | EASTLAND JULIA MARIE | CFO & VP, Corp. Dev ... | Option Exercise | A | 3.31 | 40,000 | 132,400 | 40,000 |
Page: 1